Skip to content

Clinical trials

Phase 2/3 Glioblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 2/3 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20142
20151
20171
20184
20192
20201
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Active, not recruiting3
Recruiting2
Not yet recruiting2
Withdrawn2
Completed1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amsterdam UMC, location VUmc1
Beijing Pearl Biotechnology Limited Liability Company1
Beijing Tiantan Hospital1
Everfront Biotech Co., Ltd.1
Global Coalition for Adaptive Research1
Grupo Español de Investigación en Neurooncología1
Johnpro Biotech, Inc.1
Laminar Pharmaceuticals1
NRG Oncology1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma16
Recurrence3
Astrocytoma2
Glioma2
Brain Neoplasms1
Gliosarcoma1
Oligodendroglioma1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.